print Medtronic

Important information about renal denervation (RDN) – read press release

Medtronic RDN:
Developing Device-Based
Approaches for Hypertension

As the prevalence of hypertension rises worldwide,1 so too does the rate of treatment-resistant hypertension. With cardiovascular risk doubling with each
20/10-mm Hg rise in blood pressure,2 addressing this severe form of hypertension is ever more urgent.

Medtronic is committed to finding an innovative solution. To learn more about renal denervation, choose the button below for your area and whether you’re a patient or healthcare professional.

  1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Lancet. 2005;365:217-223.
  2. Lewington S, Clarke R, Qizilbash N, et al, and The Prospective Studies Collaboration. Lancet. 2002;360:1903-1913.